Repligen
RGEN
#1864
Rank
A$15.82 B
Marketcap
A$247.48
Share price
-3.81%
Change (1 day)
2.92%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): A$45.65 Million

According to Repligen 's latest financial reports the company's current earnings are A$0.80 Billion. In 2025 the company made an earning of A$0.12 Billion, an increase over its 2024 earnings that were of -A$9.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$45.65 M-63.98%
2025 A$0.12 B-1430.84%
2024 -A$9.53 Million-113.01%
2023 A$73.19 M-78.01%
2022 A$0.33 B33.37%
2021 A$0.24 B131.52%
2020 A$0.10 B101.31%
2019 A$53.54 M25.93%
2018 A$42.52 M105.61%
2017 A$20.68 M-11.46%
2016 A$23.35 M14.91%
2015 A$20.32 M20.26%
2014 A$16.9 M-51.49%
2013 A$34.84 M90.98%
2012 A$18.24 M
2010 A$0.26 M-103.81%
2009 -A$6.94 Million-223.84%
2008 A$5.59 M
2006 -A$3.76 Million229.64%
2005 -A$1.15 Million-89.16%
2004 -A$10.53 Million-16.86%
2003 -A$12.66 Million88.72%
2002 -A$6.71 Million-27.88%
2001 -A$9.3 Million-1.74%
2000 -A$9.47 Million85.93%
1999 -A$5.1 Million159.16%
1998 -A$1.97 Million85.71%
1997 -A$1.06 Million-70.83%
1996 -A$3.63 Million-72.41%
1995 -A$13.15 Million-60.63%
1994 -A$33.39 Million45.39%
1993 -A$22.97 Million39.45%
1992 -A$16.47 Million-32.3%
1991 -A$24.33 Million6.62%
1990 -A$22.82 Million1577.78%
1989 -A$1.36 Million-57.14%
1988 -A$3.18 Million-362.5%
1987 A$1.2 M-130.77%
1986 -A$3.93 Million136.36%
1985 -A$1.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.52 B 22,613.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$11.93 B 25,648.09%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$17.74 B 38,188.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.12 B 36,838.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-459.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.34 Billion-828.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.30 B 2,713.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.37 B 715.93%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$65.96 M 42.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$0.16 Billion-426.66%๐Ÿ‡บ๐Ÿ‡ธ USA